MD995Z - Method for treating Herpes simplex virus type 1 and 2-induced infection - Google Patents
Method for treating Herpes simplex virus type 1 and 2-induced infectionInfo
- Publication number
- MD995Z MD995Z MDS20150006A MDS20150006A MD995Z MD 995 Z MD995 Z MD 995Z MD S20150006 A MDS20150006 A MD S20150006A MD S20150006 A MDS20150006 A MD S20150006A MD 995 Z MD995 Z MD 995Z
- Authority
- MD
- Moldova
- Prior art keywords
- acyclovir
- herpes simplex
- simplex virus
- virus type
- treating herpes
- Prior art date
Links
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
The invention relates to medicine, in particular to a method for treating Herpes simplex virus type 1 and 2-induced infection.According to the invention, the method consists in carrying out the clinical and paraclinical examination of the patient and initiation of etiotropic therapy with acyclovir, and of anti-inflammatory, sedative, analgesic, local, immunomodulatory and vitamin-therapeutic treatment, at the same time within 12…24 hours after the clinical examination is carried out the acyclovir sensitivity testing of virus strains taken from herpetic vesicles, and in case of detection of acyclovir-resistant strains, it is replaced from the second day of treatment with an antiviral drug with thymidine kinase-independent action based on human recombinant interferon α-2b.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MDS20150006A MD995Z (en) | 2015-01-27 | 2015-01-27 | Method for treating Herpes simplex virus type 1 and 2-induced infection |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MDS20150006A MD995Z (en) | 2015-01-27 | 2015-01-27 | Method for treating Herpes simplex virus type 1 and 2-induced infection |
Publications (2)
Publication Number | Publication Date |
---|---|
MD995Y MD995Y (en) | 2016-01-31 |
MD995Z true MD995Z (en) | 2016-08-31 |
Family
ID=55235465
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MDS20150006A MD995Z (en) | 2015-01-27 | 2015-01-27 | Method for treating Herpes simplex virus type 1 and 2-induced infection |
Country Status (1)
Country | Link |
---|---|
MD (1) | MD995Z (en) |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SU491387A1 (en) * | 1974-07-18 | 1975-11-15 | Всесоюзный Научно-Исследовательский Институт Лекарственных Растений | Flavonoid compounds exhibiting antiherpetic activity |
SU1246005A1 (en) * | 1984-07-13 | 1986-07-23 | Московский научно-исследовательский институт вирусных препаратов | Method of estimating pharmacological activity of chemical drugs for curing genital herpes |
SU1530189A1 (en) * | 1988-04-15 | 1989-12-23 | Научно-Исследовательский Институт Эпидемиологии И Микробиологии Им.Почетного Акад.Н.Ф.Гамалеи | Method of treatment of recurring herpes simplex |
SU1720649A1 (en) * | 1981-08-06 | 1992-03-23 | Институт Биоорганической Химии Ан Узсср | Antiherpetic remedy "megosine" |
MD1051C2 (en) * | 1996-12-02 | 1999-05-31 | Centrul National Stiintifico-Practic De Igiena Si Epidemiologie Al Ministerului Sanatatii Din Republica Moldova | Antiherpetic remedy |
MD1473F2 (en) * | 1998-06-02 | 2000-05-31 | Centrul National Stiintifico P | Antiherpetic remedy |
RU2492861C1 (en) * | 2012-05-29 | 2013-09-20 | Закрытое акционерное общество "Вектор-Медика" (ЗАО "Вектор-Медика") | Method of treating recurrent genital herpes with chronic fatigue symptoms |
-
2015
- 2015-01-27 MD MDS20150006A patent/MD995Z/en not_active IP Right Cessation
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SU491387A1 (en) * | 1974-07-18 | 1975-11-15 | Всесоюзный Научно-Исследовательский Институт Лекарственных Растений | Flavonoid compounds exhibiting antiherpetic activity |
SU1720649A1 (en) * | 1981-08-06 | 1992-03-23 | Институт Биоорганической Химии Ан Узсср | Antiherpetic remedy "megosine" |
SU1246005A1 (en) * | 1984-07-13 | 1986-07-23 | Московский научно-исследовательский институт вирусных препаратов | Method of estimating pharmacological activity of chemical drugs for curing genital herpes |
SU1530189A1 (en) * | 1988-04-15 | 1989-12-23 | Научно-Исследовательский Институт Эпидемиологии И Микробиологии Им.Почетного Акад.Н.Ф.Гамалеи | Method of treatment of recurring herpes simplex |
MD1051C2 (en) * | 1996-12-02 | 1999-05-31 | Centrul National Stiintifico-Practic De Igiena Si Epidemiologie Al Ministerului Sanatatii Din Republica Moldova | Antiherpetic remedy |
MD1473F2 (en) * | 1998-06-02 | 2000-05-31 | Centrul National Stiintifico P | Antiherpetic remedy |
RU2492861C1 (en) * | 2012-05-29 | 2013-09-20 | Закрытое акционерное общество "Вектор-Медика" (ЗАО "Вектор-Медика") | Method of treating recurrent genital herpes with chronic fatigue symptoms |
Non-Patent Citations (2)
Title |
---|
Герпесвирусная инфекция. Под редакцией В.П. Малого. Москва, Медицинская практика, 2009, p. 36-57 * |
Исаков В.А., Архипова Е.И., Исаков Д.В. Герпесвирусные инфекции человека (руководство для врачей). Санкт-Петербург, 2006, p. 276-282 * |
Also Published As
Publication number | Publication date |
---|---|
MD995Y (en) | 2016-01-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Mehandru et al. | The gastrointestinal tract is critical to the pathogenesis of acute HIV-1 infection | |
Peng et al. | Protective effect of fluvastatin on influenza virus infection | |
Lv et al. | Curcumin inhibits human cytomegalovirus by downregulating heat shock protein 90 | |
Severa et al. | Three decades of interferon-β in multiple sclerosis: can we repurpose this information for the management of SARS-CoV2 infection? | |
Trivedi et al. | A meta-analysis comparing efficacy of continuous terbinafine with intermittent itraconazole for toenail onychomycosis | |
MD995Y (en) | Method for treating Herpes simplex virus type 1 and 2-induced infection | |
RU2014117294A (en) | 4,6-DI (3,12-DIAZA-6,9-DIAZONIADISPIRO [5.2.5.2] HEXADECAN-1-IL) -2-METHYL-5-NITROPYRIMIDINE TETRACHLORIDE DIHYDROCHLORIDE HEXAHYDRATE FOR THE TREATMENT OF CHEMISE | |
Karateev et al. | Efficacy of combined use of glycosaminoglycan peptide complex for intramuscular administration and oral diacerein in osteoarthritis: evaluation according to an observational multicenter clinical trial | |
Seung et al. | Adult-onset Still’s disease: a case report | |
Dubois-Laforgue et al. | Fulminant type 1 diabetes in the course of drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome | |
RU2008113615A (en) | METHOD FOR TREATING INFECTIONS CAUSED BY FIRST AND SECOND TYPES SIMPLE VIRUS, CYTOMEGALOVIRUS, EPSTEIN-BARR VIRUS | |
Izzo et al. | Herpetic whitlow | |
Kalyuzhin et al. | Clinical and interferon-modulating efficacy of a combination of rectal and topical dosage forms of interferon-α2b in acute respiratory infections | |
Erfanian et al. | Treatment of COVID-19 patients using plasma therapy | |
Gaus | Social science and the complexity of tropical medicine | |
Shroff et al. | Host autophagy response: friend or foe in reproductive tract infections | |
Pinzone et al. | Comment about “Lymphomas and other cancers in HIV-infected patients” | |
Yasue Ishii-Osai et al. | Infliximab treatmenteinduced paradoxical psoriasiform reaction in patient with psoriasis vulgaris showing positive lymphocyte transportation test reaction | |
Nakamura | Pure red cell aplasia: case report | |
Insaniputri | Comparison of Zidovudine Combination and Tenofovir Combination to The Effectiveness of Therapy in HIV/AIDS Patients in RSAL Mintohardjo | |
UA130761U (en) | METHOD OF TREATMENT OF ENDOMETRITIS INDUCED BY GENITAL HERPESVIRUS INFECTION | |
Kovalenko et al. | The study of ganciclovir’s clinical safety in patients with cytomegalovirus infection | |
Mottaghi | Neurotoxicity: case report | |
Li | Interferon α 2b | |
Gallais Sérézal et al. | Atypical Ulcerations of the Penis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG9Y | Short term patent issued | ||
MK4Y | Short term patent expired |